Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.
| Autor: | Khambata-Ford S, Garrett CR, Meropol NJ, Basik M, Harbison CT, Wu S, Wong TW, Huang X, Takimoto CH, Godwin AK, Tan BR, Krishnamurthi SS, Burris HA 3rd, Poplin EA, Hidalgo M, Baselga J, Clark EA, Mauro DJ |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 8/1/2007, Vol. 25 Issue 22, p3230-3237, 8p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|